Quantification of iron concentration in the liver by MRI

被引：55

作者：

Alústiza Echeverría J.M. ^{[1
]}

Castiella A. ^{[2
]}

Emparanza J.I. ^{[3
]}

机构：

[1] Osatek-Donostia Hospital, 20014 San Sebastián

[2] Gastroenterology Unity Mendaro Hospital, Mendaro

[3] Clinic Epidemiology Unity, Donostia Hospital, San Sebastián

来源：

Insights into Imaging | 2012年 / 3卷 / 2期

关键词：

Haemochromatosis; Iron overload; Liver iron; MRI; Quantification; Relaxometry; Signal intensity ratio;

D O I：

10.1007/s13244-011-0132-1

中图分类号：

学科分类号：

摘要：

Objective Measurement of liver iron concentration is a key parameter for the management of patients with primary and secondary haemochromatosis. Magnetic resonance imaging (MRI) has already demonstrated high accuracy to quantify liver iron content. To be able to improve the current management of patients that are found to have iron overload, we need a reproducible, standardised method that is, or can easily be made, widely available. Methods This article discusses the different MRI techniques and models to quantify liver iron concentration that are currently available and envisaged for the near future from a realistic perspective. Results T2 relaxometry methods are more accurate than signal intensity ratio (SIR) methods and they are reproducible but are not yet standardised or widely available. SIR methods, on the other hand, are very specific for all levels of iron overload and, what is more, they are also reproducible, standardised and already widely available. Conclusions For these reasons, today, both methods remain necessary while progress is made towards universal standardisation of the relaxometry technique. © European Society of Radiology 2011.

引用

页码：173 / 180

页数：7

共 32 条

[1]

Brittenham G.M., Badman D.G., Non invasive measurement of iron: Report of an NIDDK workshop, Blood, 101, pp. 15-19, (2003)

[2]

Pietrangelo A., Deugnier Y., Dooley J., Et al., EASL clinical practice guidelines for HFE haemochromatosis. European Association for the Study of the Liver, J Hepatol, 53, pp. 3-22, (2010)

[3]

Allen K.J., Gurrin L.C., Constantine C.C., Et al., Iron-overloadrelated disease in HFE hereditary haemochromatosis, N Engl J Med, 358, pp. 221-230, (2008)

[4]

Villeneuve J.P., Bilofdeau M., Lepage R., Et al., Variability in hepatic iron concentration measurement from needle-biopsy specimens, J Hepatol, 25, pp. 172-177, (1996)

[5]

Ambu R., Crisponi G., Sciot R., Et al., Uneven hepatic iron and phosphorus distribution in beta-thalassemia, J Hepatol, 23, pp. 544-549, (1995)

[6]

Crisponi G., Ambu R., Cristiani F., Et al., Does iron concentration in a liver needle biopsy accurately reflect hepatic iron burden in beta-thalassemia?, Clin Chem, 46, pp. 1185-1188, (2000)

[7]

Emond M.J., Bronner M.P., Carlson T.H., Et al., Quantitative study of the variability of hepatic iron concentrations, Clin Chem, 45, pp. 340-346, (1999)

[8]

St Pierre T.G., Clark P.R., Chua-Anusorn W., Et al., Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance, Blood, 105, pp. 855-861, (2005)

[9]

Alexopoulou E., Stripeli F., Baras P., Et al., R2 relaxometry with MRI for the quantification of tissue iron overload in betathalassemic patients, J Magn Reson Imaging, 23, pp. 163-170, (2006)

[10]

Anderson L.J., Holden S., Davis B., Et al., Cardiovascular T2- star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload, Eur Heart J, 22, pp. 2171-2179, (2001)

← 1 2 3 4 →